1. What the law is
A Kansas bill won a favorable committee report and then died without a floor vote. House Bill 2218 would have moved a future FDA-approved crystalline polymorph psilocybin product to Schedule IV. The House passed over it and struck it from the calendar on Turnaround Day, and the Legislature has since adjourned. Psilocybin stays in Schedule I, where possession is prohibited.
Kansas splits the job across two statutes. K.S.A. 65-4105 places psilocybin in Schedule I of the Kansas Uniform Controlled Substances Act, and K.S.A. 21-5706 is the provision a possession charge is brought under. Manufacture and distribution are prohibited statewide as well. No Kansas statute authorizes therapeutic, supervised or personal use of psilocybin.
HB 2218 would not have legalized psilocybin generally. It carved one future product out of the Schedule I definition, and by its own terms even that waited on federal FDA approval and DEA rescheduling. It never received a floor vote.
2. Trials in Kansas
Interventional psilocybin trials with at least one site in Kansas, as their sponsors filed them with ClinicalTrials.gov, EU CTIS and ISRCTN. Each row links to the registry record, which sets out who may take part.
Recruiting or opening counts trials recruiting now, not yet recruiting, or enrolling by invitation. Closed counts trials terminated, suspended, withdrawn or left unverified by their sponsors.
| Registry ID | Trial | Phase | Sponsor | Status | Start date |
|---|---|---|---|---|---|
| NCT05478278 | An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics (opens in new tab)Site at Altasciences Clinical Kansas, Inc, Overland Park | Phase Phase 1 | Sponsor Usona Institute | Status Completed | Start date |
ClinicalTrials.gov data courtesy of the U.S. National Library of Medicine.
3. History
The legal events behind this entry, dated and oldest first. Our own reviews and corrections are listed under Changes to this record.
Kansas House Health and Human Services Committee issued a favorable committee report recommending passage of HB 2218, which would place a future FDA-approved crystalline polymorph psilocybin product in Schedule IV.
HB 2218 was passed over in Committee of the Whole on February 18, 2026 and stricken from the calendar under House Rule 1507 on February 19, 2026, Turnaround Day. It never received a floor vote and died with the 2025-2026 biennium.
4. Proposed laws
No proposed law is on file in Kansas that would change this entry, as of the 01 Aug 2026 review.
5. Common questions
Is psilocybin legal in Kansas?
No. Psilocybin is a Schedule I controlled substance under the Kansas Uniform Controlled Substances Act (K.S.A. 65-4105), and its possession, manufacture, and distribution are prohibited. No Kansas law authorizes therapeutic or personal use.
What is Kansas House Bill 2218?
HB 2218 (2025-2026) is a proposed trigger law that would exclude a future FDA-approved pharmaceutical crystalline polymorph psilocybin product from the Schedule I psilocybin definition and place it in Schedule IV. It received a favorable House committee report on January 28, 2026, was passed over in Committee of the Whole on February 18, 2026, and was stricken from the calendar under House Rule 1507 on February 19, 2026. It never received a floor vote and was not enacted.
Would HB 2218 have made psilocybin legal to use in Kansas?
No. Even if enacted, HB 2218 would not legalize psilocybin generally. It applies only to a specific FDA-approved crystalline polymorph product and is contingent on federal FDA approval and DEA rescheduling, so it would create no current legal access in Kansas.
Has Kansas decriminalized psilocybin?
No. Kansas has not decriminalized or legalized psilocybin. It remains a Schedule I controlled substance and possession is enforced as a drug offense under Kansas law.
Are magic mushrooms ("shrooms") legal in Kansas?
"Magic mushrooms" and "shrooms" are common names for fungi that contain psilocybin, and this entry states the law on psilocybin itself, which some laws treat separately from the fungus. Psilocybin is illegal in Kansas.
Read the law
None enacted. HB 2218 (2025-2026), an FDA-trigger law placing FDA-approved crystalline polymorph psilocybin in Schedule IV, received a favorable House committee report on January 28, 2026, was passed over in Committee of the Whole on February 18, 2026, and was stricken from the calendar under House Rule 1507 on February 19, 2026, the biennium's Turnaround Day; it died with the April 10, 2026 sine die.1
Sources
This entry's status is checked against the primary sources below, and the methodology explains how each entry is graded for confidence.
- 1.kslegislature.gov (opens in new tab) · kslegislature.gov
- 2.kslegislature.gov (opens in new tab) · kslegislature.gov
This entry is for information only and is not legal or medical advice. Laws change, and enforcement can differ from the letter of the law, so check the current position against the primary sources above before relying on it.
Changes to this record
3 changes on file, the latest on . Show allHide
Every change we have made to this record, dated, corrections included. Nothing changes silently.
Kansas's FDA-trigger psilocybin bill died on the House calendar on Turnaround Day in February, and the legislature has adjourned. Nothing is pending.
The supporting citation for HB 2218 moves from a bill-tracking site to the Kansas Legislature's own note on the bill. We use trackers to find bills and official pages to say what they contain.
Kansas moves from mixed to illegal. Its only psilocybin bill, which depended on a future FDA approval, stalled on the House calendar and died without becoming law.
Psilocybin Media Group. "Kansas: psilocybin legal status." The Psilocybin Record, accession US-KS-001, version of 23 Aug 2026. https://psilocybinlegalization.com/record/kansas